Background. Tuberculosis is the second leading cause of infectious disease mortality (1.8 million/year), after HIV/AIDS. There are more than 9 million new cases each year. One-third of the world's population, and 50% of adults in sub-Saharan Africa, South Asia, and South-East Asia, are infected, representing an enormous pool of individuals at risk for developing the disease. The situation is complicated by the HIV/AIDS pandemic, widespread undernutrition, smoking, diabetes, increased mobility, and emergence of multi-and extensively drugresistant tuberculosis.
Introduction Tuberculosis, the infection
Tuberculosis, the world's leading bacterial cause of death in humans, is usually caused by an infection with Mycobacterium tuberculosis* [2] and is most often transmitted from person to person through coughing and contaminated droplets in the air. Most people in whom M. tuberculosis penetrates the epithelial barrier of the lungs (first line of defense), i.e., who are initially infected with M. tuberculosis, develop what is termed a primary infection. This is an initial response by the body that generally results in containment of the disease. Such a contained infection is termed a latent infection. It is believed that nearly one-third of the S346 R. D. Semba et al. world's population is infected with tuberculosis, and that 95% of these have the infection in this asymptomatic, noncontagious, latent form.
A small proportion of people (approximately 5%) will develop active, usually contagious, tuberculosis immediately after initial exposure to M. tuberculosis. This is termed primary progressive disease. The risk of developing primary progressive disease after exposure to M. tuberculosis is higher in those who are undernourished or who have immune compromise, such as that due to infection with the human immunodeficiency virus (HIV).
The same conditions-i.e., undernutrition* or compromised immunity due to HIV/AIDS, immunosuppressive therapy, or cancer-can lead to reactivation of latent tuberculosis when the immune system is no longer able to contain and prevent M. tuberculosis from developing into clinical disease.
Most infected people have a healthy immune system that represses, but does not eliminate, M. tuberculosis. In an HIV-negative population, approximately 10% of people infected with M. tuberculosis will become ill with active tuberculosis during their lifetime, 5% will develop primary progressive tuberculosis within the first 5 years after exposure, and another 5% will develop active tuberculosis at a subsequent time in their lives [3] . In contrast, HIV-positive people coinfected with M. tuberculosis have a risk of reactivation of latent tuberculosis of 5% to 10% per year and are also at higher risk for primary progressive disease when they become infected with M. tuberculosis after contracting HIV [3] .
Active tuberculosis is generally classified as pulmonary or extrapulmonary. Pulmonary disease, which affects the lungs, accounts for about 80% of cases of tuberculosis, is more contagious because coughing spreads contaminated air droplets, and is diagnosed through sputum tests that identify M. tuberculosis. Extrapulmonary disease can occur at nearly any site but is most common in lymph nodes, the linings of the lungs (pleura) or brain (meninges), kidneys and bones or joints. The symptoms are various and less easily detected. Miliary tuberculosis is a disseminated form that has spread in the blood to various parts of the body and accounts for 1% to 2% of all cases of tuberculosis. * "Undernutrition" refers to lack of nutrition, which can be in the form of wasting, stunting, or micronutrient deficiencies. "Malnutrition" refers to "wrong" nutrition, which includes both undernutrition and overnutrition (i.e., also including overweight, obesity, and diabetes). Both forms of malnutrition can occur within the same individual; for example, one can be stunted, overweight, and suffering from micronutrient deficiencies. Some common terminology, such as "severe acute malnutrition" (SAM), uses "malnutrition" where "undernutrition" would nowadays be more appropriate. To limit confusion, but admittedly reducing clarity about which conditions are meant exactly, this paper predominantly uses the term "malnutrition. "
Both extrapulmonary tuberculosis and miliary tuberculosis are more common in immunosuppressed patients (especially those with HIV coinfection) and in young children, and when not accompanied by the persistent cough of pulmonary tuberculosis they are more difficult to detect and diagnose because these individuals usually have no positive sputum test.
The classification of tuberculosis infection is determined by diagnostic criteria. Detection of M. tuberculosis confirms active disease. Sputum tests confirm pulmonary tuberculosis, and tests of pleural fluid, pleural tissue, or lymph node specimens can confirm extrapulmonary tuberculosis. A positive tuberculin skin test confirms that the person has developed an immune response to M. tuberculosis, either from having inhaled live M. tuberculosis or from immunization with BCG vaccine. When BCG vaccine has been given at birth, the tuberculin skin test can still be used to determine infection, sometimes with a higher cutoff point. This is not the case when the BCG vaccine was given later in life (i.e., a positive test can indicate either immunization or infection). Tuberculosis infection and active tuberculosis can still occur in an immunized person.
Thus, latent infection is defined by the host immune response, as detected through a response to the tuberculin skin test, rather than the identification of the bacteria, which is used to detect active tuberculosis [2] . Clinically latent tuberculosis means the absence of confirmed, active tuberculosis and is detected by a positive skin test and/or tuberculosis lesions detected on a chest x-ray and also an inability to culture M. tuberculosis.
It is unknown what proportion of people inhale M. tuberculosis but do not develop a primary infection and what factors affect this first-line host defense, because there is no indicator that a person has previously inhaled M. tuberculosis. In addition, the tuberculin skin test can give a false negative result, for example, in case of malnutrition [4] .
Records of tuberculosis are known from the times of the Egyptian Pharaohs, and recent genotype tracing suggests that it was a health issue in Neanderthal times [5] . It is now clear that different strains of M. tuberculosis emerged from Africa and progressed through different populations, with certain types still concentrated more in some populations than in others [5] . There is a tendency, therefore, to refer to the Mycobacterium tuberculosis complex, especially when different prevention and treatment options might in the future be developed for different strains [5] .
Epidemiology of tuberculosis and of HIV coinfection
Worldwide, tuberculosis is the second leading cause of death from infectious disease, after HIV/AIDS, accounting for nearly 1.8 million deaths annually [6] .
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Addressing tuberculosis
About one-third of the world's population, or 2 billion people, are infected with M. tuberculosis, which represents an enormous pool of individuals who are at risk for developing the disease in the future. In sub-Saharan Africa, the Indian subcontinent, and South-East Asia, half or more of all adults have latent tuberculosis. Worldwide, there are over 9 million new cases each year of active tuberculosis, the vast majority in sub-Saharan Africa and Asia. Tuberculosis is responsible for about a quarter of all preventable deaths in developing countries. Many tuberculosis deaths are associated with underlying HIV infection, because HIV infection lowers immunity and increases the risk of reactivation tuberculosis and of primary progressive disease.
The current global situation of tuberculosis is complicated by several factors: the evolving HIV/AIDS pandemic, widespread undernutrition, smoking, diabetes, the emergence of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis [7, 8] , and the increased mobility of populations. In some areas, wars, natural disasters, and refugee crises are exacerbating the spread of tuberculosis. In 2007, of the 10.4 million episodes of tuberculosis (first and subsequent), 4.9% (511,000) were cases of MDR tuberculosis, accounting for 3.1% of all new cases and 19% of all previously treated cases [6] . MDR tuberculosis (marked by resistance to rifampicin and isoniazid, with or without other drug resistance) and XDR tuberculosis (marked by resistance to rifampicin and isoniazid, any fluoroquinolone, and at least one of the three injectable second-line drugs: capreomycin, amikacin, or kanamycin) represent major threats to the global control of tuberculosis.
Among the 9.27 million incident cases of tuberculosis in 2007, an estimated 1.37 million (14.8%) were HIV positive, with the African Region accounting for most (79%) HIV-positive tuberculosis cases, followed by the South-East Asia Region (mainly India), with 11% of the total cases [6] . With a widespread prevalence of latent tuberculosis infection (up to one of every two adults in Africa and Asia), the immunosuppression of HIV infection markedly increases the incidence of active tuberculosis. In 2007, 22 million people were living with HIV in sub-Saharan Africa [9] . This equates to potentially 11 million cases of active tuberculosis infection, in addition to tuberculosis in the absence of HIV coinfection. Lönnroth et al. [7] estimated a relative risk of active tuberculosis for HIV infection of 26.7% and a population-attributable fraction of 19% (table 1) .
Why focus on tuberculosis and nutrition?
The relationship between undernutrition and active tuberculosis infection has been known for millennia. The disease has been associated with "consumption" and wasting because of the loss of weight often seen in patients. Good food, sunshine, and healthy living were the presumed best ways to address this disease, often with a treatment that included cod liver oil [10] . Although no class or group was immune, the poor living in unhealthy and crowded conditions were then, as now, at higher risk. Figure 1 shows the decline in tuberculosis deaths in England and Wales between 1838 and 1967 [11] . McKeown [11] hypothesized that the decline in tuberculosis mortality was largely the result of improvements in standards of living and nutrition rather than advances in medicine, such as antibiotics, because most of the decline occurred before these advances were introduced.
The relationship between tuberculosis and nutrition is bidirectional: having active tuberculosis leads to loss of weight, and being underweight is a known risk factor for developing tuberculosis, whether through the reactivation of latent tuberculosis or the development of progressive primary disease upon infection. Among the known risk factors for active tuberculosis (undernutrition, HIV infection, diabetes, alcohol abuse, smoking, and indoor air pollution), undernutrition has the highest population-attributable fraction of 27% (see table 1 in Lönnroth et al. [7] ).
This paper reviews the available information on nutrition and tuberculosis, undernutrition (malnutrition) as a risk factor, and good nutritional status as a preventive intervention and as an adjunct to treatment. We examine the relationships among tuberculosis and HIV coinfection and nutrition, because both undernutrition and HIV infection are risk factors for the development of active tuberculosis. The role of the greatly increased numbers of people with type 2 diabetes who are exposed to tuberculosis in low-and middle-income countries will also be considered. The purpose is therefore to review current knowledge regarding the relationships among tuberculosis, undernutrition (including deficiencies of micronutrients and some other dietary components), and HIV/AIDS, as the epidemiology and pathophysiology of the three factors are interrelated and converge to increase the threat of morbidity and death [12] . The natural history of tuberculosis can vary widely, according to whether the person who becomes infected is undernourished and whether the person also has HIV infection ( fig. 2) . The review also focuses on the gaps in the scientific knowledge and implications of current knowledge for addressing the nutritional needs of people with active tuberculosis.
Relationship between nutrition and tuberculosis
Above, we have discussed the different stages of tuberculosis infection. Below, we review what is known about the relationship between nutrition, and undernutrition in particular, and tuberculosis, from the risk of becoming infected (i.e., developing primary pulmonary tuberculosis) to the impact on progression to active tuberculosis, whether in the first 5 years after infection (primary progressive disease) or by reactivation of latent infection.
It is unknown whether malnutrition affects the risk of primary pulmonary tuberculosis
In order to develop primary pulmonary infection, a person needs to inhale tubercle bacilli, and these need to enter the body by passing through the lining of the lungs. For this to happen, a patient must produce, by coughing, viable aerosols of small particle size that are transmitted by air to another person, and in the person who inhales these aerosols, the tubercle bacilli must make it through to the alveoli of the lungs, permeate the epithelial barrier, and be ingested by weakly endowed alveolar macrophages. This requires inhalation of not 1 but between 3 and 300 bacilli [13] .
There is little direct evidence that malnutrition affects the risk of developing primary pulmonary infection with M. tuberculosis upon inhalation of the bacilli. The measure of primary infection is conversion of a tuberculin skin test. This confirms that a person developed the infection after contact with a person with active pulmonary tuberculosis. The tuberculin skin test is affected by malnutrition, which increases the likelihood of a false negative result [4] . For malnutrition to affect the risk of developing primary pulmonary infection, there needs to be a relationship between nutritional status and epithelial integrity and macrophage endowment (nonspecific "killer capacity"), i.e., the first line of the body's defense. Vitamin A deficiency and severe malnutrition can impair epithelial defenses and are also associated with an increased risk of developing primary progressive disease (see below). Therefore, distinguishing the risk of developing primary pulmonary infection from the risk of developing primary progressive disease is difficult, but the latter cannot occur without the former.
Malnutrition may increase the risk of primary progressive disease
The evidence with regard to malnutrition increasing the risk of primary progressive disease, i.e., developing tuberculosis immediately after infection, and increasing the risk of reactivation disease, i.e., where a latent infection develops into active tuberculosis, is stronger. This relationship is attributed to the negative impact of macronutrient and micronutrient deficiencies on the cell-mediated immune system [7, 14, 15] . Primary progressive tuberculosis occurs in approximately 5% of individuals immediately after initial exposure to M. tuberculosis. It usually occurs in otherwise healthy children and young adults who have not been previously exposed to M. tuberculosis, and clinically apparent disease appears within 5 years of the initial infection [16] . Primary progressive disease is more common in low-to middle-income countries.
Primary progressive disease has been studied in a few settings in which tuberculosis outbreaks occurred shortly after tuberculin skin testing had been conducted in the general population. The skin testing allowed the scientists to determine whether people had no infection or latent tuberculosis infection prior to the outbreaks. In 1956, an epidemic of primary progressive tuberculosis occurred in Bergen, Norway.
The source of the outbreak was traced to a woman who worked in a local shop. Customers were exposed to her coughing. Forty-two people who previously had negative tuberculin skin tests, and who therefore had no pre-existing tuberculosis infection, developed primary progressive tuberculosis; 24 of these were aged 6 to 14 years and 18 were 15 or more years of age [17] . Other epidemics of primary progressive disease in Europe have been documented from the Faroe Islands [18] and Norway [19] . The degree of exposure to M. tuberculosis resulting from coughing or spitting and crowding was identified as increasing the risk of primary progressive disease [17] .
Some insight into the possible role of micronutrients in the risk of primary progressive disease comes from a study conducted in the 1940s in Harlem, New York City. The trial was conducted to determine whether a vitamin and mineral supplement could reduce the incidence of active tuberculosis in families who had a household case of tuberculosis. One hundred ninetyfour families received either a vitamin and mineral supplement or no supplement. The attack rate of tuberculosis was 0.16/100 person-years in families who took the vitamins and minerals and 0.91/100 person-years among families in the control group [20] .
Young children are at high risk for developing primary progressive disease, and the risk appears to be higher among malnourished children and children under 3 years of age [21] . In Ethiopia, tuberculosis was found among about one-quarter of children aged 4 to 60 months who were admitted for hospitalization with severe protein-energy malnutrition [22] .
Malnutrition increases the risk of active tuberculosis in people with latent tuberculosis infection
Although 2 billion people worldwide are infected with M. tuberculosis, about 90% of infected people, without HIV coinfection, never develop clinical disease. Reactivation disease can develop in people who are malnourished, as malnutrition can impair the immunologic responses to M. tuberculosis infection and allow the infection to become active tuberculosis. Similarly, immunosuppression due to HIV, cancer, or specific medical treatment also impairs the immunologic response and allows latent infection to develop into active disease.
Diet and tuberculosis risk
Some older observational studies from wartime conditions also support the contention that malnutrition increases the risk of active tuberculosis. During World War I, Denmark exported much of its meat and dairy products, and new cases of tuberculosis increased in the country. In 1918, after a German submarine blockade, Denmark could no longer export these foods, and these foods of high dietary quality then became available again for its inhabitants. Tuberculosis rates decreased, while the rates continued to increase in surrounding countries [23] . Around the same time, high rates of tuberculosis were found in a naval training school in Norway and were attributed to crowding, poor housing, and lack of hygiene. However, after housing and hygiene were improved, the tuberculosis rate did not decrease. The diet was subsequently modified with the addition of cod liver oil, whole wheat bread, fresh fruits and vegetables, and milk, and tuberculosis morbidity dropped [24] . During World War II, British and Russian prisoners of war were held in German camps under similar conditions of housing, living, and work conditions. The prisoners had the same basic diet, except that the British prisoners received extra food rations from the Red Cross consisting of meat, butter, cheese, milk powder, and other foodstuffs. The incidence of active tuberculosis among the Russian prisoners was 15 times higher than that among the British prisoners, and the only environmental difference between the two groups was the extra food received by the British [25] .
Wasting and tuberculosis risk
An inverse relationship between nutritional status, measured as the amount of subcutaneous fat in the body, and the incidence of clinical tuberculosis was found in prospective studies of US naval recruits and of a population in Muscogee County, Georgia, USA [26] . A recent paper that examined this relationship in greater detail, using data from several affluent countries, found a consistent log-linear relationship between tuberculosis incidence and body mass index (BMI) within a BMI range from 18.5 to 30 kg/m 2 , i.e., tuberculosis incidence increased exponentially as BMI decreased [27] . Because there were few data on people with BMI under 18.5 kg/m 2 , the authors could not confirm that BMI under 18.5 kg/m 2 is a risk factor for tuberculosis and therefore part of the diagnosis of tuberculosis, but extending the relationship of increased risk to lower BMI values makes intuitive sense. Nevertheless, it has been pointed out that now with the epidemic of obesity and noncommunicable diseases, and their increasing concentration in poor and disadvantaged populations, often with high levels of both HIV infection and diabetes, this "typical" profile of a wasted tuberculosis patient may no longer be diagnostic, for example, in populations in South Africa of overweight but at-risk adult women [6] .
The most important conclusion, based on observational data, is that promoting adequate nutrition and weight gain in undernourished populations and shifting the overall BMI distribution in a population to higher values would reduce the incidence of tuberculosis [27] .
Micronutrient status and tuberculosis risk
A longitudinal study of 1,100 men was conducted in a low-income area of Philadelphia, USA, in the 1940s to determine whether nutritional deficiencies increased the risk of developing tuberculosis [28] . At baseline, vitamin A, vitamin C, hemoglobin, albumin, calcium, and phosphorus were measured, and all subjects had chest x-rays to exclude those with evidence of tuberculosis. The subjects were followed for 7 years, and 28 men subsequently developed tuberculosis. Participants with low initial plasma levels of both vitamins A and C at baseline had a significantly increased risk of developing active tuberculosis during the follow-up period.
The BCG vaccination response appears to be reduced in malnourished individuals
BCG is the mostly widely used vaccine worldwide to prevent tuberculosis infection, but its protection is both incomplete and variable. The reduction in the risk of tuberculosis has varied from 0% to 80% [29] . BCG mainly provides protection against disseminated forms of tuberculosis [30] . Following BCG vaccination, children will often exhibit a positive tuberculin skin test, reflecting that their body has developed an immune response to the tubercle bacillus, although reactivity to the tuberculin skin test wanes over time, especially if BCG is given at birth. Severe malnutrition seems to reduce the response to BCG vaccination.
In Baltimore, USA, children with mild-to-moderate protein-energy malnutrition and well-nourished control children were immunized with BCG. After nutritional rehabilitation, some of the originally malnourished children became well nourished, while some children remained malnourished. After tuberculin skin testing, the area of induration was reduced in the malnourished children, intermediate in the children who were formerly malnourished and were now well nourished, and highest in the control children [31] . In a study from West Bengal in the 1970s, 292 children aged 2 to 6½ years underwent tuberculin (purified protein derivative) skin testing. There were 240 children who were tuberculin skin test negative, and these children were given BCG immunization. After tuberculin skin testing 6 to 8 weeks after BCG immunization, children with protein-energy malnutrition had significantly lower positivity to skin testing than children who were not malnourished [32] . In India, 270 children aged 1 to 5 years were given BCG immunization. Tuberculin skin testing was conducted 5 to 6 months later, and lower positivity was noted only among children who had kwashiorkor (a severe form of protein-energy malnutrition) [33] . In an experimental animal model, guinea pigs received M. bovis BCG vaccination and then were placed on low-protein or adequate-protein diets for 5 weeks. The animals were then challenged with virulent S351 Addressing tuberculosis M. tuberculosis. Protein-deficient animals had less protection from the BCG vaccination than proteinsufficient animals [34] . Since BCG is currently usually given at birth, it is unclear how nutritional status at birth influences the effectiveness of BCG.
Malnutrition is also associated with tuberculosis in children
Relatively less is known about the nutritional status of children with tuberculosis. Children with severe protein-energy malnutrition are at a higher risk for developing tuberculosis [22] . A study of children with pneumonia in The Gambia suggests that M. tuberculosis is not an uncommon cause of pneumonia, especially among children who are malnourished [35] . In Bulawayo, Zimbabwe, an autopsy series of 184 children under 5 years of age who died at home showed that tuberculosis was present in 4%, and all of the children who died with tuberculosis had marasmus [36, 37] .
Both tuberculosis and HIV infection were independent risk factors for growth failure among children in India [38] . Malnutrition and diarrhea were common presentations among HIV-infected children with culture-proven tuberculosis [39] .
Relationship between HIV and tuberculosis
As mentioned in the Introduction, HIV and tuberculosis coinfection is frequently seen, particularly in sub-Saharan Africa, because there is a large pool of people with latent tuberculosis infection (one in two adults), HIV infection affects the immune system, and therefore the tuberculosis infection can develop into active disease. The evidence for the relationship between HIV infection and tuberculosis infection is presented in the following section.
HIV infection increases the risk of primary progressive disease
The risk of primary progressive disease is higher in people with HIV infection, as shown in a welldocumented outbreak of active tuberculosis in newly tuberculosis-exposed HIV-infected patients in San Francisco [40] . Active tuberculosis was diagnosed in 12 residents of a housing facility for HIV-infected patients, and molecular methods were used to identify the culture isolates from those with active tuberculosis. In the 6 months prior to the outbreak, two patients admitted to the facility were undergoing treatment for tuberculosis. Active tuberculosis developed in nearly 40% of the residents who were exposed to possible M. tuberculosis infection. These findings showed that newly acquired tuberculosis infection can progress to active disease within 6 months in 30% to 40% of HIV-positive patients [40] .
HIV-infected children who are exposed to tuberculosis are at high risk for developing progressive primary disease [41] .
HIV infection increases the risk of active tuberculosis in people with latent tuberculosis infection
HIV-infected adults with advanced disease have an extremely high risk of reactivation of tuberculosis. As noted previously, among those with latent tuberculosis infection, HIV-negative individuals have about a 5% lifetime risk of reactivation of tuberculosis, whereas HIV-positive individuals have a 5% to 10% risk per year of reactivation [3] . Among individuals with a positive tuberculin skin test, the risk of disease depends upon the population involved. In cohort studies of injection drug users, the risk is high, about 7% to 12% per year [42] . In Africa, for HIV-positive adults, the risk for reactivation ranges from three to eight cases per 100 HIV-positive per 100 person-years of observation [43, 44] . Among HIV-infected individuals with cutaneous anergy (i.e., nonresponsive to skin tests, regardless of type of antigen used for the test) to tuberculin and other skin test antigens (e.g., candida, mumps, tetanus), there appears to be an increased risk of developing active tuberculosis compared with those without anergy [45] .
Among adults with active tuberculosis, the HIV seroprevalence rates are high. An estimated 14.8% of total incident cases of active tuberculosis occurred among HIV-positive people in 2007 [6] . In sub-Saharan Africa, the seroprevalence rates of HIV infection in adults with tuberculosis range from 20% to over 75% [12, 46] . In Zambia, the seroprevalence of HIV among children aged 1 to 14 years who were hospitalized with tuberculosis was 37% [47] . The highest age-specific prevalence rate of 53% was found in the 12-to 18-month-old children diagnosed with tuberculosis. In Côte d'Ivoire, of 298 children under 15 years of age with tuberculosis, 11.8% were HIV positive, and the highest age-specific HIV prevalence rate of 23.4% was found in children 1 to 4 years of age [48] . In Western Cape Province, South Africa, the incidence of culture-confirmed tuberculosis among HIV-infected and -uninfected infants was 1,596 and 65.9 cases per 100,000 population, respectively [49] .
Relationships among HIV, nutrition, and tuberculosis
Tuberculosis infection is strongly related to HIV infection, and both infections are, alone as well as together, strongly related to undernutrition. Together, they are also known as the triple burden [12] . Here, we explore this triple relationship in greater detail. 
Active tuberculosis as well as HIV infection increases the risk of malnutrition, and tuberculosis and HIV coinfection increases the severity of malnutrition Macronutrients
Tuberculosis has also been known as "consumption, " which refers to weight loss, a common sign in people suffering from tuberculosis. A low BMI has been commonly reported among adults with tuberculosis [50] [51] [52] . Tuberculosis increases the risk of malnutrition, and in turn, malnutrition impairs the body's ability to fight the disease. The inflammatory state, which is not exclusive to tuberculosis, increases resting energy expenditure as well as reducing appetite through effects on the hypothalamus. Patients develop a negative energy balance, metabolize body stores of fat and protein (from muscle tissue), and are at higher risk for wasting. It is important to note that the reduced energy intake is much more likely to be the primary driving force of weight loss in tuberculosis (as well as in HIV infection) than the increased basal metabolic rate, which is often compensated for by reducing physical activity.
Furthermore, the inflammation of active tuberculosis causes an "anabolic block, " i.e., utilization of amino acids for protein synthesis is impaired [53] , which makes it difficult to regain muscle tissue when still suffering from active tuberculosis. This anabolic block appears to be stronger for tuberculosis than for HIV infection. Body composition studies have not shown large differences between HIV-positive and HIV-negative adults with tuberculosis, but a study in India found that malnutrition was greatest among patients with both tuberculosis and HIV infection [54] . Body cell mass (an indicator of fat-free, or lean, body mass), among other indicators of nutritional status, significantly decreases with increasing severity of HIV disease [51, [54] [55] [56] [57] . The potential contribution of malabsorption to loss of body cell mass has not been well characterized in tuberculosis or in tuberculosis and HIV coinfection.
The reduced food intake, as well as increased utilization of energy (fat and protein stores) and specific micronutrients, leads to weight loss and micronutrient deficiencies, such as anemia. Diagnosis of micronutrient deficiencies is challenging, though, because of the acute-phase response, which leads to reduced circulating levels of some micronutrients, such as serum retinol, and increased levels of others, such as serum ferritin (a complex of iron, reflecting its body stores), both in the absence of a change in body stores of these micronutrients.
In adults with pulmonary tuberculosis who developed respiratory failure, serum albumin and hemoglobin were strong predictors of survival [58] . In adults with miliary tuberculosis (clinical disease resulting from uncontrolled hematogenous dissemination of M. tuberculosis), a nutritional risk score, based on BMI, albumin, cholesterol, and lymphocyte count, was strongly predictive of respiratory failure, which has a high fatality rate [59] .
Micronutrients
Cross-sectional studies show that, in general, micronutrient malnutrition is more prevalent in people with tuberculosis than in healthy people.
Vitamin A. Clinic-based studies using different indicators of vitamin A status suggest that vitamin A deficiency is common among adults and children with tuberculosis. Low circulating vitamin A levels [60] [61] [62] [63] , depleted hepatic stores of vitamin A [64, 65] , and nightblindness [66, 67] have been described in adults with tuberculosis. In a large study of children from the island province of Cebu in the Philippines, xerophthalmia was associated with tuberculosis [68] . In a cross-sectional study in Rwanda, 29% of adults with tuberculosis and HIV coinfection had serum vitamin A concentrations indicative of deficiency (< 1.05 μmol/L) [69] . Factors that may contribute to the development of vitamin A deficiency during tuberculosis include decreased dietary intake of vitamin A, impaired absorption of vitamin A [70] , increased utilization of vitamin A during infection, and abnormal losses of vitamin A in the urine.
Vitamin D and calcium. It has been postulated that vitamin D deficiency is associated with tuberculosis [71] . Unlike other respiratory diseases, the seasonality of tuberculosis in the United Kingdom shows a peak incidence in the summer, a time that follows the preceding season of low sunlight exposure and low levels of vitamin D [72] . Hypovitaminosis D might increase the risk of tuberculosis because of the effects of vitamin D on immune function [73] , and in vitro studies suggest that vitamin D status may influence resistance to tuberculosis. Cultured human monocytes and macrophages were protected against virulent tubercle bacilli by 1,25(OH 2 )-vitamin D 3 , an active metabolite of vitamin D [74] [75] [76] [77] . 1,25(OH 2 )-vitamin D 3 may enhance the effects of pyrazinamide against tuberculosis [78] . Studies in vitamin D-deficient guinea pigs suggest that dietary vitamin D levels influence immunity to virulent M. tuberculosis [79] . A case-control study from London showed that vitamin D deficiency was associated with tuberculosis and suggested that polymorphisms in the vitamin D receptor gene were associated with susceptibility to tuberculosis [80] . Vitamin D deficiency was common among adults with pulmonary tuberculosis in Tanzania [81] .
Abnormalities in calcium homeostasis have been reported in patients with tuberculosis, and the relationship of these abnormalities to vitamin D status is unclear. In persons with untreated pulmonary tuberculosis, calcium levels have been reported to be decreased [82] , increased [83, 84] , or normal [85] compared with S353 Addressing tuberculosis those in healthy controls, and vitamin D levels are reported to be normal during active tuberculosis [86, 87] . It has been suggested that plentiful sunlight may be the cause of high levels of vitamin D and calcium in patients in Africa [84] . Isoniazid and rifampicin treatment for tuberculosis has been reported to depress [88] or have no effect [89] on vitamin D levels. Similarly, chemotherapy for tuberculosis has been reported to increase [90] , decrease [91] , or have no effect [92] on calcium levels.
B-complex vitamins. In a study in Nigeria, no differences were noted in serum vitamin B 12 concentrations between adults with tuberculosis and blood donors [93] . Vitamin B 12 was elevated and folate concentrations were mostly normal in a study of adults with severe pulmonary tuberculosis in London [94] . Low plasma vitamin B 6 concentrations have been described in patients with pulmonary tuberculosis [95] . Decreased serum folate concentrations were found in adults with tuberculosis in Nigeria, but red cell folate concentrations were normal [96] . Low serum and red cell folate concentrations were found in patients with miliary tuberculosis [96] . Low serum folate concentrations were common in adults with tuberculosis, both before and during tuberculosis chemotherapy [63, 97, 98] .
Vitamin C. Decreased serum vitamin C concentrations have been described in patients with pulmonary tuberculosis in Russia [99] , Nepal [100] , and Ethiopia [101] .
Vitamin E. Adults with pulmonary tuberculosis had lower serum vitamin E concentrations than healthy controls in India [102] and Nepal [100] .
Trace elements. A case-control study from Miami, USA, showed that 12 people with tuberculosis were more likely to have low plasma selenium concentrations than 32 healthy controls [103] . In Malawi, among 801 adults with pulmonary tuberculosis, zinc and selenium deficiency occurred in 85% and 87%, respectively [51] . Another study from Malawi suggested that there is an association between selenium deficiency and anemia in adults with pulmonary tuberculosis [104] . In Ethiopia, lower serum zinc and selenium concentrations have been described in patients with tuberculosis and in patients with tuberculosis and HIV coinfection than in healthy controls [52] .
Malnutrition increases the risk of death in people with tuberculosis and HIV coinfection
Wasting is associated with an increased risk of death among patients with tuberculosis [58, , as well as among people suffering from HIV disease .
HIV coinfection appears to be a much stronger risk factor for mortality in adults with pulmonary tuberculosis than is malnutrition alone. In a study from Tanzania, factors that predict mortality in adults with pulmonary tuberculosis, with or without HIV coinfection, were age, HIV infection, CD4 lymphocyte count, hemoglobin, HIV load, and oral thrush [111] .
Micronutrient malnutrition also has been associated with an increased risk of death in adults with tuberculosis and HIV coinfection. In a study from Uganda of over 500 adults coinfected with tuberculosis and HIV, low serum vitamin A concentrations were independently predictive of mortality after adjustment for age, sex, BMI, CD4 lymphocyte count, and diarrheal morbidity [112] .
Relationship between drug treatment for tuberculosis and for HIV infection and nutritional status
The increased risk of death due to malnutrition among people suffering from tuberculosis, HIV infection, or both warrants treatment that reduces malnutrition by increasing body weight due to both lean tissue (muscle) and fat mass as well as ensuring adequate micronutrient status. Because the inflammatory state, marked by tissue catabolism and poor appetite, is primarily responsible for the negative energy balance during infection, the question is whether the malnourished state will decrease automatically once pharmaceutical treatment of the infection is initiated or whether reducing malnutrition also requires nutrition interventions, i.e., a specific diet and/or special supplements. These issues are discussed below.
Tuberculosis chemotherapy improves nutritional status
Tuberculosis chemotherapy treats the infection, and therefore nutritional repletion occurs, provided that substrate intake is adequate, i.e., nutrient intake meets the body's demands for tissue regeneration by providing building blocks for muscles and fat stores. These demands are still high, because the increased resting energy expenditure associated with the infection remains elevated for quite a while after the start of treatment, and the body needs to recover lost fat and fat-free mass, which together may amount to 10 kg (approximately 5 kg each).
In adults with pulmonary tuberculosis in Malawi, weight, mid-upper-arm circumference (MUAC), and serum albumin upon admission to the hospital were lower than in controls, and these nutritional indices improved during treatment with effective chemotherapy, irrespective of the clinical, nutritional, and radiographic features of tuberculosis upon admission [50, 113] . A study of nutritional status in 148 adults with smear-positive pulmonary tuberculosis in Tanzania showed that 77% of men and 58% of women had a BMI under 18.5 kg/m 2 upon admission [114] . In general, adults gained weight during 6 months of chemotherapy, but some of the weight that was gained was lost after treatment had finished. The length of stay in the hospital was the primary determinant of weight gain in patients on chemotherapy, suggesting that nutritional intake in the hospital was better than could be achieved at home. A study of Asian patients in the United Kingdom reported that serum albumin levels and MUAC were still subnormal 12 months after they had started chemotherapy, suggesting that body protein reserves (which are largely muscle tissue) were not fully recovered during treatment [115] . A study in London also found that during microbiologic treatment of tuberculosis, patients largely gained fat mass and that protein mass (or fat-free mass) was not yet restored after they had completed the 6 months of treatment successfully. The authors contributed this to an ongoing anabolic block [116] .
Thus, in principle, chemotherapy will result in improved nutritional status, but how fast that occurs and whether all tissue losses will be recovered depends on other factors as well, such as nutrient intake, and improvement could also potentially be enhanced by medication that promotes muscle growth (anabolic hormones, such as growth hormones) or reduces the impact of inflammation, for example, by reducing the levels of tumor necrosis factor-α by using thalidomide [117] . However, it should be noted that thalidomide, in addition to having potent anti-inflammatory effects, is also strongly teratogenic.
ART improves nutritional status
In developing countries, people with HIV have had increasing access to HIV medications, including highly active antiretroviral therapy (HAART), which consists of treatment with at least three HIV medications from four different types of drugs [118] . HAART has strong effects in improving immunity in people with HIV and reduces the risk of opportunistic infections. HAART reduces gastrointestinal infections and thus improves absorption of micronutrients. HAART is generally associated with improvement in micronutrient status [118] . Although HAART has reduced the incidence of wasting, HIV-associated weight loss is still often seen in adults with HIV [119] .
Impact of nutritional status and food intake on tuberculosis treatment
There is a considerable amount of information and patient advice with regard to antiretrovirals and food intake (timing, combinations, side effect mitigation, etc.). However, little information is available with regard to tuberculosis medication. In general, taking the medication with food can help ease feelings of nausea. A negative impact of taking medication with food has not been consistently demonstrated for tuberculosis medication [120, 121] , and when it has been found, its magnitude has been limited [120, 122] . The only medicine that patients are advised to take without food is rifampicin, because absorption of the drug is reduced when it is taken with fat. However, absorption of rifampicin is apparently unaffected by consumption of protein and carbohydrates, and therefore it could be consumed with a non-fat-containing porridge or with tea or coffee and toast with jam [122, 123] .
Nutritional interventions for people with active tuberculosis and for people with active tuberculosis and HIV coinfection
As reviewed above, pharmaceutical treatment of tuberculosis and HIV infection generally improves nutritional status by reversing the inflammatory state and thus stopping tissue catabolism and improving appetite. Adequate nutrition should accompany treatment of HIV and tuberculosis, because malnutrition affects the immune system and thus increases the risk of death. The reduction of malnutrition also requires the consumption of foods that contain appropriate and adequate nutrients for rebuilding the tissues that have been lost during the course of the disease. It is important to note that adequate nutrition can be ensured in different ways, including nutrition education as well as provision of specially formulated foods to patients who have limited access to nutritious foods. Here, we review the documented impact of nutrition interventions among people with tuberculosis and among people with tuberculosis and HIV coinfection.
Nutritional interventions can strengthen pharmaceutical treatment in people with tuberculosis, especially during the first phase of treatment
Historically, the interaction between tuberculosis and nutrition was well recognized, as shown by observational studies and the practice of giving cod liver oil to children. When pharmacological treatment became available, the additional contribution that good nutrition could make to clinical outcomes became relatively limited, especially when the diet also was concurrently improved (in more affluent countries). The emergence of HIV infection and of MDR and XDR tuberculosis among populations suffering from food insecurity and malnutrition has recently increased interest in the issue of nutrition and tuberculosis, and important studies in this area are currently being undertaken that should guide tuberculosis and HIV treatment and control programs in the near future.
Nutritional interventions have been evaluated as an adjunct for adults receiving chemotherapy for S355 Addressing tuberculosis tuberculosis. There have been two main types of study, one aimed at achieving a faster or more favorable impact of tuberculosis treatment, and the second aimed at improving the nutritional status of patients on tuberculosis treatment. In terms of nutrition or food interventions, three categories can be distinguished: macronutrients (high protein content, energy), micronutrients, and other nutrients that may directly support the immune system (arginine, cholesterol). Most studies have focused on micronutrients, with the primary outcome evaluated being tuberculosis sputum conversion and weight gain. These studies are reviewed below.
Macronutrients
In a study that assessed the effects of early nutritional intervention on lean mass and physical function in patients with tuberculosis and wasting, patients who started antituberculous therapy were randomly assigned to receive either standard nutritional counseling or high-energy and protein supplements in addition to nutritional counseling to improve their nutritional intake. After 6 weeks, patients in the nutritional supplement group (n = 19) had a significantly greater increase in body weight, total lean mass, and grip strength than did the control subjects (n = 17) [124] .
Another more recently reported trial in Dili, Timor-Leste, provided daily prepared meals (meat, kidney beans, vegetable stew, and rice) for the first 8 weeks and a food package (kidney beans, rice, and oil, enough for one meal per day) to take home for the next 24 weeks as adjunct to tuberculosis treatment for one group and nutritional advice only as adjunct to therapy to another group. There was no difference in treatment adherence or outcome between the groups, but the group receiving food had a greater weight gain than the control group at 6 months (10.1% vs. 7.5%) and also at earlier time points. Among sputum smear-positive patients, the proportion with sputum-negative smears 1 month after treatment initiation was higher in the food group (85%, n = 40) than in the control group (67%, n = 37). The authors reported that the lack of impact of the provision of food on treatment adherence may be related to the fact that families were not so much affected by food insecurity [125] . In other words, the impact of the food intervention depends on the total change in the diet that it induces.
Micronutrients
In a more recent placebo-controlled trial from Indonesia [126] , daily supplements of vitamin A and zinc given to adults with pulmonary tuberculosis led to significant improvements in the lesion area observed on chest radiographs after 2 months of tuberculosis chemotherapy; a difference no longer existed at the 6-month follow-up. The supplements resulted in earlier clearance of tubercle bacilli from sputum smears. However, no effects of the supplements were observed on the number of cavities, the surface area of cavities, hemoglobin concentration, or anthropometric indicators of nutritional status. In another trial from the former Soviet Union conducted on 110 patients with newly diagnosed active tuberculosis, the subjects received tuberculosis chemotherapy alone or in addition to injectable thiamine, vitamin B 6 , or vitamin C, or an oral multivitamin supplement. All groups receiving any vitamin supplementation had significantly better lymphocyte proliferation responses (in response to phytohemagglutinin or purified protein derivative) than the group not receiving vitamin supplements [127] . Another trial showed that vitamins C and E were effective in improving immune responses to tuberculosis when given as adjuncts to multidrug tuberculosis therapy [128] . In a placebo-controlled trial from Guinea-Bissau in adults with pulmonary tuberculosis, of whom about one-third had HIV infection, vitamin D supplementation had no impact on the severity of disease or mortality [129] .
Other nutrients
Cholesterol and arginine have both been found to play a role in the immune system in the two small studies presented here. Cholesterol has been found to be important for the cytotoxic function of human lymphocytes [130] , and therefore it was hypothesized that hypocholesterolemia in tuberculosis patients could have a detrimental effect on cellular immunity that could potentially be mitigated by increasing cholesterol intake. In a study in Mexico, the participants received a daily diet (2,500 kcal/day with 30% of energy from fat) with either 250 or 800 mg/day of cholesterol [131] . At the end of the second week of treatment, 8 of 10 patients in the high-cholesterol group versus 1 of 11 patients in the low-cholesterol group had negative sputum cultures. By week 4, the percentages were 90% and 73%, respectively. It should be noted that although serum cholesterol changes did not differ between the two groups, the authors hypothesized that patients consuming the high-cholesterol diet replenished metabolic pools faster than control patients. This level of cholesterol supplied for 8 weeks did not raise LDL cholesterol levels or LDL/HDL cholesterol ratios to levels that are associated with an increased risk of cardiovascular disease. The faster conversion to negative sputum cultures reduces the risk of dissemination of bacilli to others. The study did not examine other, longer-term treatment outcomes.
Arginine is necessary for the formation of nitric oxide, which appears to be important for human host resistance, involving cellular immunity, during the acute phase of tuberculosis. In a study in Ethiopia, 120 smear-positive patients received either arginine (1 mg/day) or placebo. Among HIV patients, those receiving arginine (n = 24) showed higher sputum conversion rates, more weight gain, and faster reduction of symptoms such as cough than those receiving placebo (n = 32) [132] . Similarly to the results for cholesterol, these findings mean that transmission of infection to others was reduced, and longer-term outcomes, or those requiring larger sample sizes, were not included in the study. Arginine is contained in groundnuts (peanuts) at a level of approximately 1 g/30 g.
Possible contraindications to certain nutrients
It has also been noted that pathogens, including M. tuberculosis, need certain micronutrients for their own metabolism, and a greater availability of these nutrients in the body may encourage their growth. Iron is considered the most likely micronutrient to have a clinical effect in this regard [133] , although the evidence is conflicting and depends on iron levels and bodily conditions [134] . Nevertheless, an extensive review for the US Agency for International Devel-US Agency for International Development (USAID) concluded that for tuberculosis, as for other infections, intake of iron beyond the requirement for correcting iron deficiency may have deleterious effects and should be avoided [135] . The actual evidence to support this contention remains limited at present.
Iron deficiency and anemia, as well as anemia from other causes such as malaria and HIV/AIDS, are commonly seen in the populations currently most susceptible to tuberculosis. Anemia is also common in patients with pulmonary tuberculosis and is more common among those who are coinfected with HIV [135] . Anemia in these patients can be due to hemoptysis, bone marrow involvement, or inadequate diet, or it can be anemia of chronic inflammation with decreased circulating iron [135, 136] . In a study from Malawi, the prevalence of anemia was higher in coinfected patients [104] . In this study, the authors also suggested that selenium deficiency may contribute to anemia through increased oxidative stress [104] .
Iron overload and iron repletion may increase the risk of adverse health outcomes. In a study in Zimbabwe, increased dietary iron was associated with an attenuation of the Th-1 immune response and a 3.5 times increased risk of developing tuberculosis, along with a 1.3 times increased risk of death, after adjustment for age, HIV status, and liver function. The suggestion was that elevated dietary iron increases the risk of activating tuberculosis [137] . Iron status is important because of the genetically influenced interaction between iron status, host immunity, and infectious agents, including M. tuberculosis and HIV [138] . A challenge is the difficulty of measuring iron levels in the field, since the inflammatory state raises serum ferritin, confusing the picture. Measurements of serum transferrin receptor, which are less affected by inflammation, are often difficult to obtain in most low-income country settings.
Low cholesterol levels are commonly seen in tuberculosis patients. Recent work has suggested a negative effect of hypercholesterolemia on resistance to tuberculosis [139] , whereas others found hypocholesterolemia to be a risk factor [131] . There is a single randomized, controlled trial in which a cholesterol-rich diet accelerated the sterilization of tuberculosis sputum samples [131] . Contradictory results have also been found with omega3:omega6 ratios [138] . There has been some discussion of a role of vitamin E supplements in possibly exacerbating the risk of tuberculosis in those with high dietary vitamin C intakes, but the analysis has been criticized [140] .
However, overall, given the lack of clear evidence and the World Health Organization (WHO) recommendation not to give iron to iron-replete individuals (children in that recommendation) in holoendemic malarious areas, it seems reasonable to be cautious in giving iron to individuals who are being treated for tuberculosis, although obvious anemia should be treated and consumption of an adequate and varied diet should be encouraged.
Few studies have yet examined the impact and outcomes of nutrition interventions in people with tuberculosis and HIV/AIDS
Macronutrients
There have been no published randomized, clinical trials of macronutrient supplementation for people with tuberculosis and HIV coinfection.
Micronutrients
Recently, three randomized, placebo-controlled clinical trials of multimicronutrient supplementation for adults with HIV infection and pulmonary tuberculosis were completed and yielded conflicting results. In a study involving 213 HIV-infected adults with pulmonary tuberculosis in Tanzania, daily supplementation with a multivitamin plus zinc for 8 months reduced mortality by 71% [141] . In contrast, a study in Malawi with a sample size of 829 HIV-infected adults with pulmonary tuberculosis that involved longer follow-up did not corroborate these findings. Daily supplementation with a multivitamin and mineral supplement for 24 months had no significant impact on mortality [142] . In Tanzania, supplementation with multiple micronutrients (vitamin A, B-complex vitamins, vitamin C, vitamin E, and selenium) reduced the risk of recurrence of tuberculosis by 63% in patients with pulmonary tuberculosis and HIV coinfection [143] . There was no significant impact of micronutrient supplementation on mortality.
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Methodological issues of studies on nutrition and tuberculosis, with or without HIV coinfection
As mentioned above, the purpose of food and nutrition interventions among tuberculosis patients has varied, and impact evaluations have been scanty, largely focusing on micronutrients provided as adjunct to tuberculosis chemotherapy for improving the outcome of tuberculosis treatment. Not much work has yet been reported on the evaluation of the impact of other nutrients and/or dietary advice; most studies have been fairly small; only a few have focused on longerterm or rarer outcomes (recurrence of tuberculosis or death); and no studies have reported the impact on prevention of the development of active tuberculosis among contacts of active cases in the context of high HIV prevalence.
Meanwhile, the primary aim of many food assistance (or food aid) interventions for tuberculosis has been to increase treatment adherence and case detection, in order to improve treatment initiation and outcome and to reduce transmission. The food provided has largely been staples and oil, primarily aimed at addressing food insecurity and improving livelihoods to support clinic attendance and treatment adherence rather than aiming at correcting nutritional deficiencies or enhancing the impact of tuberculosis treatment by supporting the immune system.
Research to date has been done with groups that are too small to permit evaluation of whether the faster weight gain obtained by treatment of the severe to moderately malnourished state in some of the intervention studies resulted in lower tuberculosis mortality. However, the increased risk of death with increasing levels of malnutrition, especially in settings where mortality is high, suggests that this could be the result.
When interpreting (and designing) such studies, it is important to distinguish between disease and nutritional outcomes, be clear about the changes in the diet when nutrition and/or food assistance is provided, and specify the local context that affects the intervention (level of food security, HIV prevalence, HIV coinfection, and disease status among study participants). For a further discussion of the design of such studies, see the review on nutrition and HIV infection by two of the authors in this Supplement [144] .
Policy implications and recommendations
The recent Cochrane review by Abba and colleagues [145] concluded that there was evidence, although limited, that providing high-energy supplements containing carbohydrate, protein, and fat to people with active tuberculosis, along with dietary assessment and advice, helps weight gain [145] . They also concluded there was some evidence that providing zinc with other multiple micronutrients or vitamin A might help treated patients gain weight, and that this combination may reduce mortality in those coinfected with HIV [145] . The authors also noted that there is a disappointing lack of evidence to assess the effectiveness of any other combination of nutrients or to assess any potential harm of iron supplementation. Our conclusions are similar. More positively, they note that several trials are currently under way or have recently been finished that should provide more data to be used in the development of treatment guidelines.
WHO, along with the Joint United Nations Pro-Joint United Nations Programme on HIV/AIDS (UNAIDS), the World Food Programme (WFP), and other key partners, recently increased its attention to the issue of nutrition and tuberculosis and held a meeting in Geneva in November 2009 on the role of nutrition in tuberculosis prevention and improvement of health outcomes in order to start the process of development of nutrition and tuberculosis guidelines [6] . food support provided (USAID-supported field research is currently looking at this in the FANTA Project). Observational studies have demonstrated the devastating effect active tuberculosis infection and/or HIV/ AIDS in one member of the family can have on the household and the larger community [146] . Therefore, the social and ecological environments in which these questions are being addressed need to be more clearly factored into any recommendations. The conclusion from a recent review of approaches to HIV programs in Africa probably applies to tuberculosis programs as well. It concluded that the approaches have been overly medicalized and called for "a comprehensive approach to link health strategies with communityoriented food-based strategies" [147] . In other words, the broader questions of food insecurity [146, 148] and the other macroeconomic shocks and environmental change need to be taken into account, since these will continue to worsen the plight of many of the poorest populations at high risk for contracting tuberculosis and often HIV as well [149, 150] . In this regard, it is important to distinguish between household food assistance for supporting treatment initiation and initial adherence, and social protection and livelihood support to support longer-term coping of households and communities. Household food assistance to support treatment would be in addition to nutrition counseling and special food supplements provided to treat malnutrition in the patient. Social protection and livelihood support are important for supporting households in the medium and longer term. This kind of support should be sensitive to HIV and tuberculosis but not exclusive to those affected by these diseases.
In the meantime, the participants at the meeting agreed that it seems reasonable, given the interaction between TB and HIV and the fact that similar populations are often affected, and in the absence of specific research but with the understanding the problem is immediate, to adopt what recommendations there are for nutritional adjunct treatment of HIV-infected patients and populations [151] . However, these recommendations are somewhat dated and were built on the best, but inadequate, evidence at the time and are in the process of being updated (see de Pee and Semba [144] in this Supplement for more discussion of HIV and nutrition). At the same time, different groups working in the field are helping to provide increasing evidence.
An overall goal for tuberculosis programming, according to the meeting's participants, might be stated as follows: To prevent active tuberculosis (reactivation as well as progressive primary), especially given the rise in MDR and XDR tuberculosis, with a focus on those most at risk (HIV-infected persons, undernourished persons, and contacts of tuberculosis cases), especially in resource-poor settings. They proposed that in the meantime, it is sensible to encourage the following: » Improve nutritional status by ensuring food security, especially at the household level, including adequacy of micronutrient intakes. » Micronutrient intakes can be increased through the use of fortified foods, lipid-based nutrient supplements, and micronutrient powders if given with other food, although, as noted, further work on this continues, and further clarity is needed on the best combinations and dosages. » Treat malnutrition in active tuberculosis cases, according to guidelines for undernourished adults and as is increasingly being implemented for HIVinfected individuals, to reduce mortality and promote recovery. » Encourage treatment adherence by providing food or other livelihood support at the individual, household, and community levels as a way of improving recovery and preventing increased drug resistance. » Support food assistance and food aid, with greater emphasis on nutritional status and on protecting the contacts of tuberculosis patients.
Conclusions
This review has shown the following: » Tuberculosis and malnutrition negatively reinforce each other. » Both HIV infection and malnutrition, because they affect the immune system, markedly increase the risk of activation of latent tuberculosis and of progressive primary tuberculosis. » The combination of widespread latent tuberculosis infection (50% among adults in Africa and in South and South-East Asia) and the high prevalence of HIV infection as well as malnutrition in certain areas of the world has markedly increased the incidence of tuberculosis. This combination is also a major threat for spreading MDR and XDR tuberculosis. » Adequate nutrition is also important for close contacts (household members) of tuberculosis patients. » Promoting adequate nutrition and weight gain in undernourished populations, and shifting the overall BMI distribution in a population to higher values, could potentially reduce the incidence of tuberculosis. » Tuberculosis treatment is a prerequisite for nutritional recovery. » However, nutritional recovery requires consumption of required nutrients (i.e., substrate availability) for rebuilding tissues lost, and this may be markedly constrained in poor, food-insecure households. » Additional pharmaceutical treatment to reduce the catabolic impact of inflammation or promote growth (anabolic hormones) can be considered, but little
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Addressing tuberculosis experience exists. » Severe and moderate malnutrition are strong risk factors for mortality among tuberculosis patients as well as HIV/AIDS patients and therefore need to be treated concurrently with treatment of the infections. It appears that the greatest gains can be made during the first stages of treatment. » Nutritional supplements (such as certain micronutrients, arginine, and cholesterol) can contribute to faster sputum smear clearance, which can be important for reducing transmission, as well as to faster weight gain, especially when combined with an (augmented) diet with adequate energy and protein contents.
The recent meeting of the United Nations agencies WHO, UNAIDS, WFP, and other partners held in Geneva in early November 2009, while recognizing that there is a limited evidence base for program guidance, reached a consensus on the questions that require further or expanded recommendations.
Existing recommendations and clinical applications need to be more widely applied, resourced, monitored, and evaluated in order to strengthen the evidence base so that recommendations can be adjusted and strengthened on the basis of better evidence.
In the meantime, the existing practices of improving nutrition and living environments, especially of those most at risk, should be continued and scaled up. The many risk factors for the development of tuberculosis, several of which have had estimates attached to them, all need to be addressed at the same time, especially including the HIV/AIDS epidemic, the context of food insecurity and undernutrition, and probably in some countries also the epidemic of diabetes.
